Prepolarized MRI at Earth Field to seek new contrasts linked to molecular events for very early detection of pathologies

Discover the project

PrimoGAIA

PrimoGaia opens up a new pathway in Magnetic Resonance Imaging (MRI) by initiating the concept of in vivo “enzymatic imaging” for a better understanding of human physiology, early detection and prognosis of diseases, monitoring of therapeutic treatment.

The project

7 partners
4 countries
H2020 FET Open
Start: 01-12-2019
end: 31-05-2023

News
#magnetic resonance imaging (MRI), #dynamic nuclear polarization (DNP), #overhauser MRI (OMRI), #enzyme activity, #ultra-low field, #contrast agents, #inflammatory diseases, #enzymatic mapping, #cost efficient sytems, #medical engineering
PrimoGAIA 3rd Steering Committee meeting
The PrimoGAIA 2nd Steering Committee was held in Turin, Italy, on the 13th of September 2022
...
Neutrophil Elastase-Activatable Prodrugs Based on an Alkoxyamine Platform to Deliver Alkyl Radicals Cytotoxic to Tumor Cells
Published in Chemistry Europe
...
2nd Periodic report
Periodic Reporting for period 2 - PRIMOGAIA
...
PrimoGAIA Interviews – Sabrina Elkhanoufi
PrimoGAIA Interviews - Sabrina Elkhanoufi
...
PrimoGAIA Interviews – Florian Fidler
PrimoGAIA Interviews - Florian Fidler
...
PrimoGAIA Interviews – Dahmane Boudries
PrimoGAIA Interviews - Dahmane Boudries
...
PrimoGAIA Interviews – Sarah Garifo
PrimoGAIA Interviews - Sara Garifo
...
PrimoGAIA Interviews – Seda Seren
PrimoGAIA Interviews - Seda Seren
...
Highly Sensitive “Off/On” EPR Probes to Monitor Enzymatic Activity
Published in Chemistry Europe
...